Wei-De Lin1,2, Fuu-Jen Tsai1,3,4,5,6. 1. Department of Medical Research, China Medical University Hospital, Taichung, Taiwan. 2. School of Post Baccalaureate Chinese Medicine, China Medical University, Taichung, Taiwan. 3. Division of Genetics and Metabolism, China Medical University Children's Hospital, Taichung, Taiwan. 4. Department of Medical Genetics, China Medical University Hospital, Taichung, Taiwan. 5. School of Chinese Medicine, China Medical University, Taichung, Taiwan. 6. Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, Taiwan.
Abstract
INTRODUCTION: Multiple myeloma (MM) is an incurable, biologically heterogeneous disease of the plasma cells, associated with older age and is more common in men. Gaucher disease, caused by mutation in acid β-glucosidase (glucocerebrosidase, GBA) gene, has been linked to multiple cancers, especially MM. Pathological accumulation of glucosylceramide and complex glycosphingolipids coupled with chronic inflammation may be the cause of cancer in patients with Gaucher disease. In this study, we hypothesized patients with MM have mutations in the GBA gene and analyzed patients with MM to determine whether they have a higher frequency of GBA variants. METHODS: Twenty-four MM samples were acquired from the Human Biobank, China Medical University Hospital, Taichung, Taiwan. GBA mutations were detected by polymerase chain reaction-directed DNA sequencing. RESULTS: We found no mutations in the coding regions of GBA in any of the 24 study subjects. However, two single-nucleotide polymorphisms, rs2070679 and rs2361534, were identified. A significant difference was observed between the study and control groups (p = 0.0028) in rs2361534 allele distribution, with the C allele frequency being higher in patients (1/48, 2.1%) than in the control group (5/3030, 0.16%, Taiwan Biobank). CONCLUSION: In this study, the sample size was limited and GBA enzyme activity was not measured; therefore, we could not establish a direct correlation between MM and GBA mutations. However, the association of rs2361534 suggests that regions around this single-nucleotide polymorphism may be involved in MM. The relationship between MM and GBA mutations remains unclear. A large sample is required for a detailed analysis of this potential relationship.
INTRODUCTION: Multiple myeloma (MM) is an incurable, biologically heterogeneous disease of the plasma cells, associated with older age and is more common in men. Gaucher disease, caused by mutation in acid β-glucosidase (glucocerebrosidase, GBA) gene, has been linked to multiple cancers, especially MM. Pathological accumulation of glucosylceramide and complex glycosphingolipids coupled with chronic inflammation may be the cause of cancer in patients with Gaucher disease. In this study, we hypothesized patients with MM have mutations in the GBA gene and analyzed patients with MM to determine whether they have a higher frequency of GBA variants. METHODS: Twenty-four MM samples were acquired from the Human Biobank, China Medical University Hospital, Taichung, Taiwan. GBA mutations were detected by polymerase chain reaction-directed DNA sequencing. RESULTS: We found no mutations in the coding regions of GBA in any of the 24 study subjects. However, two single-nucleotide polymorphisms, rs2070679 and rs2361534, were identified. A significant difference was observed between the study and control groups (p = 0.0028) in rs2361534 allele distribution, with the C allele frequency being higher in patients (1/48, 2.1%) than in the control group (5/3030, 0.16%, Taiwan Biobank). CONCLUSION: In this study, the sample size was limited and GBA enzyme activity was not measured; therefore, we could not establish a direct correlation between MM and GBA mutations. However, the association of rs2361534 suggests that regions around this single-nucleotide polymorphism may be involved in MM. The relationship between MM and GBA mutations remains unclear. A large sample is required for a detailed analysis of this potential relationship.
Authors: Barry E Rosenbloom; Neal J Weinreb; Ari Zimran; Katherine A Kacena; Joel Charrow; Elizabeth Ward Journal: Blood Date: 2005-02-17 Impact factor: 22.113
Authors: Carla Perrotta; Anthony Staines; Mary Codd; Silke Kleefeld; Dominique Crowley; Andrea T' Mannetje; Nicholas Becker; Paul Brennan; Silvia De Sanjosé; Lenka Foretova; Marck Maynadié; Alexandra Nieters; Paolo Boffetta; Pierluggi Cocco Journal: J Occup Med Toxicol Date: 2012-12-14 Impact factor: 2.646
Authors: Derralynn Hughes; Maria Domenica Cappellini; Marc Berger; Jan Van Droogenbroeck; Maaike de Fost; Dragana Janic; Theodore Marinakis; Hanna Rosenbaum; Jesús Villarubia; Elena Zhukovskaya; Carla Hollak Journal: Br J Haematol Date: 2007-07-26 Impact factor: 6.998